InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Explore the complete record of transactions filed by Patzer Eric, 董事. Director active across 1 company, notably Aridis Pharmaceuticals, Inc.. In total, 3 disclosures have been logged. Split: 2 buys · 0 sell. Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Eric Patzer serves as a Director at Aridis Pharmaceuticals, Inc. As a board member, he participates in overseeing the company's activities and making strategic decisions. Eric brings valuable experience in the pharmaceutical sector, enabling him to assess growth and innovation opportunities. His role is crucial in ensuring compliance and transparency in governance.